Article

Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell engagers

2023-07-10

Abstract excerpt

Over the past decade, an increasing number of immunotherapies aiming to improve the ability of the immune system to effectively eradicate tumor cells have been developed. Among them, targeting effector T cell subsets of the immune system with bispecific antibodies, called T Cell Engagers (TCEs), represents an attractive strategy. TCEs are designed to specifically direct cytotoxic T cells towards tumor cells, there...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8f86b856-a545-5eef-89c5-16fca01a140a
DOI: 10.1101/2023.07.10.548307

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell engagersDOI 10.1101/2023.07.10.548307Read

Cancer Immunotherapy Using γδT Cells: Dealing with DiversitySemantic proximity Read

CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.Semantic proximity Read

Cytotoxic CD8+ T cells in cancer and cancer immunotherapySemantic proximity Read

Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.Semantic proximity Read

Novel Approaches to Enhance the Specificity and Safety of Engineered T CellsSemantic proximity Read

A novel single TCR gamma chain fused with antibody-based binding domain facilitates T cell cytotoxicity for potent anti-tumor response without forming TCR-CD3 complexSemantic proximity Read

Role of γδ T Cells in Cancer Progression and Therapy.Semantic proximity Read

Progress of research on γδ T cells in colorectal cancer (Review)Semantic proximity Read

The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagersSemantic proximity Read

Engineering human Mucosal Associated Invariant T (MAIT) cells with chimeric antigen receptors for cancer immunotherapy <sup>1</sup>Semantic proximity Read

Novel Humanized and Highly Efficient Bispecific Antibodies Mediate Killing of Prostate Stem Cell Antigen-Expressing Tumor Cells by CD8+ and CD4+ T CellsSemantic proximity Read

The potential of γδ CAR and TRuC T cells: An unearthed treasureSemantic proximity Read